Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.

Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.

PURPOSE:Most patients suffering from advanced lung cancer die within a few months. To exploit new therapy regimens we need better methods for the assessment of a therapy response. MATERIAL AND METHODS:In a pilot study we prospectively enrolled 36 patients with advanced NSCLC and SCLC (34 stage IV, 2...

Full description

Bibliographic Details
Main Authors: Bernd Schmidt, Julia Beyer, Dimo Dietrich, Ines Bork, Volker Liebenberg, Michael Fleischhacker
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4326280?pdf=render

Internet

http://europepmc.org/articles/PMC4326280?pdf=render

Similar Items